INFLECTION POINT ACQUISITION CORP. IV

The deal closed March 16, 2026, and this is the first look at post-combination financials: cash burn is heavy (~$50.9M operating cash outflow in 6M), warrant liabilities ballooned to $130.1M, and a $60.8M deemed dividend on Series A Preferred reflects a down-round. The company asserts 12-month liquidity sufficiency, but revenue is minimal and declining.

Cash rose $60.8 million in the quarter while the company burned $27.8 million on an Adjusted EBITDA basis, so the increase is financing rather than operations. The IAI arrangement is expressly a non-binding memorandum of understanding, and the $100 million-plus figure is a contract ceiling — the maximum orderable under an IDIQ vehicle, not awarded revenue.

The registered securities are unusually layered and each layer is a separate claim on the equity: 164,748,772 common shares, 10,288,021 Series A preferred, warrants over a further 24,248,102 common shares, and 25,425,000 rights that convert at one tenth of a share each — roughly 2,542,500 shares. Counting only the common line would understate the potential share count materially. The existence of a Special Committee approving alongside the full board indicates the transaction was treated as requiring independent review. The domestication moves shareholder rights to Delaware law before closing.

The registered securities come in five separate lines and each is a distinct claim on the equity: 164,748,772 common shares, 10,288,021 Series A preferred, warrants over a further 24,248,102 common shares, 25,425,000 rights converting at one tenth of a share each, and 453,821 units. Reading the common-stock line alone understates the potential share count. The Special Committee approving alongside the full board signals the deal was treated as requiring independent review. No vote date and no redemption deadline are stated in this portion.

This is the baseline version and it already carries the full five-line registered structure: common stock, Series A preferred, investor warrants, rights converting at one tenth of a share, and units. The preferred and warrant lines sit outside the common-stock figure and must be counted separately when sizing dilution. Approval by a Special Committee in addition to the full board indicates the transaction was handled as one needing independent review. No vote date and no redemption deadline are set.

A wholesale change of sponsor management in July 2025 followed by a business combination agreement four weeks later means the team that took public shareholders' money is not the team completing the deal - the Merlin Labs transaction was negotiated by new principals under a new name. Class A and Class B voting together as a single class lets the founder block count toward the two-thirds threshold. Redemption at trust is the alternative to backing an unfamiliar sponsor.

What changed: Post-merger Merlin, Inc. (formerly BACQ) filed its first 10-Q showing $183.6M cash as of June 30, 2026, a May 2026 PIPE raising $80M gross, zero outstanding debt, but a $148.8M net loss for the six months and $700M accumulated deficit. Revenue declined to $3.2M (6M YTD) from $4.0M prior year, with >90% from the U.S. government. Why it matters: The deal closed March 16, 2026, and this is the first look at post-combination financials: cash burn is heavy (~$50.9M operating cash outflow in 6M), warrant liabilities ballooned to $130.1M, and a $60.8M deemed dividend on Series A Preferred reflects a down-round. The company asserts 12-month liquidity sufficiency, but revenue is minimal and declining.

What changed: Merlin, Inc. (Nasdaq: MRLN) furnished a press release dated August 13, 2026 reporting second quarter 2026 results. Total revenue was $2.2 million against $1.0 million in the first quarter of 2026; GAAP net loss was $(58.4) million against $(90.4) million in the first quarter; Adjusted EBITDA loss was $(27.8) million against $(23.3) million. Why it matters: Cash rose $60.8 million in the quarter while the company burned $27.8 million on an Adjusted EBITDA basis, so the increase is financing rather than operations. The IAI arrangement is expressly a non-binding memorandum of understanding, and the $100 million-plus figure is a contract ceiling — the maximum orderable under an IDIQ vehicle, not awarded revenue.